HK1216843A1 - 用於施用奧昔布寧的方法和組合物 - Google Patents

用於施用奧昔布寧的方法和組合物

Info

Publication number
HK1216843A1
HK1216843A1 HK16104715.8A HK16104715A HK1216843A1 HK 1216843 A1 HK1216843 A1 HK 1216843A1 HK 16104715 A HK16104715 A HK 16104715A HK 1216843 A1 HK1216843 A1 HK 1216843A1
Authority
HK
Hong Kong
Prior art keywords
oxybutynin
administration
compositions
methods
Prior art date
Application number
HK16104715.8A
Other languages
English (en)
Inventor
Cook Robert
a byron David
Fleming Scott
Original Assignee
Microdose Therapeutx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/728,706 external-priority patent/US9119777B2/en
Application filed by Microdose Therapeutx Inc filed Critical Microdose Therapeutx Inc
Publication of HK1216843A1 publication Critical patent/HK1216843A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16104715.8A 2012-12-27 2016-04-25 用於施用奧昔布寧的方法和組合物 HK1216843A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/728,706 US9119777B2 (en) 2008-05-30 2012-12-27 Methods and compositions for administration of oxybutynin
PCT/US2013/074759 WO2014105446A1 (en) 2012-12-27 2013-12-12 Methods and compositions for administration of oxybutynin

Publications (1)

Publication Number Publication Date
HK1216843A1 true HK1216843A1 (zh) 2016-12-09

Family

ID=51021931

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16103431.3A HK1215396A1 (zh) 2012-12-27 2016-03-23 用於施用奧昔布寧的方法和組合物
HK16104715.8A HK1216843A1 (zh) 2012-12-27 2016-04-25 用於施用奧昔布寧的方法和組合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK16103431.3A HK1215396A1 (zh) 2012-12-27 2016-03-23 用於施用奧昔布寧的方法和組合物

Country Status (15)

Country Link
EP (1) EP2938329A4 (zh)
JP (1) JP2016504358A (zh)
KR (1) KR20150100902A (zh)
CN (1) CN104955444A (zh)
AR (1) AR094287A1 (zh)
AU (1) AU2013368298B2 (zh)
BR (1) BR112015015421A2 (zh)
CA (1) CA2895955A1 (zh)
EA (1) EA201591218A1 (zh)
HK (2) HK1215396A1 (zh)
IL (1) IL239623A0 (zh)
MX (1) MX2015008333A (zh)
NZ (1) NZ628479A (zh)
UY (1) UY35230A (zh)
WO (1) WO2014105446A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3421049B1 (en) * 2016-02-25 2020-07-29 Hisamitsu Pharmaceutical Co., Inc. Liquid external preparation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003500354A (ja) * 1999-05-20 2003-01-07 セプラコール， インク． Ｓ−オキシブチニンを用いる喘息の治療方法
US6339107B1 (en) * 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
CA2498189A1 (en) * 2002-10-29 2004-05-13 Pharmacia & Upjohn Company Llc Quaternary ammonium compounds
GB0410398D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
CA2585122A1 (en) * 2004-10-25 2006-05-04 Schering Corporation M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
US8415390B2 (en) * 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
CA2716936C (en) * 2008-02-26 2018-06-05 Elevation Pharmaceuticals, Inc. Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
AU2010260513A1 (en) * 2009-06-16 2012-02-02 Wen Tan Use of R-Bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
GB0918450D0 (en) * 2009-10-21 2009-12-09 Innovata Ltd Composition
WO2011120779A1 (en) * 2010-04-01 2011-10-06 Chiesi Farmaceutici S.P.A. Process for preparing carrier particles for dry powders for inhalation
CA2812952A1 (en) * 2010-09-27 2012-04-12 Microdose Therapeutx, Inc. Methods and compositions for disease treatment using inhalation

Also Published As

Publication number Publication date
KR20150100902A (ko) 2015-09-02
WO2014105446A1 (en) 2014-07-03
BR112015015421A2 (pt) 2017-07-11
JP2016504358A (ja) 2016-02-12
AR094287A1 (es) 2015-07-22
CN104955444A (zh) 2015-09-30
AU2013368298A1 (en) 2015-07-02
EA201591218A1 (ru) 2015-11-30
EP2938329A1 (en) 2015-11-04
IL239623A0 (en) 2015-08-31
NZ628479A (en) 2016-06-24
EP2938329A4 (en) 2016-08-10
CA2895955A1 (en) 2014-07-03
MX2015008333A (es) 2015-11-09
HK1215396A1 (zh) 2016-08-26
UY35230A (es) 2015-01-30
AU2013368298B2 (en) 2016-08-11

Similar Documents

Publication Publication Date Title
HK1251246A1 (zh) 用於使組合物脫硫的方法和組合物
ZA201508059B (en) Compositions and methods of use of phorbol esters
EP2836224A4 (en) COMPOSITIONS OF BIOZOOSE AND RELATED METHODS
AP3965A (en) Anthelminitic compounds and compositions and method of using thereof
EP2675471A4 (en) HSA-RELATED COMPOSITIONS AND USE PROCESSES
HRP20180633T1 (hr) Postupak za pripremu i provedbu smjese goriva
HK1216503A1 (zh) 用於經皮傳遞安非他命的組合物及方法
HK1203815A1 (zh) 藥物組合物和其製備方法
EP2897639A4 (en) IMPROVED VACCINE COMPOSITIONS AND METHODS OF USE
HK1203149A1 (zh) 阿貝特羅的新劑型和製劑
EP2906041A4 (en) COMPOSITIONS AND METHODS OF USING INAPPETENCE COMPOUND
EP2867199A4 (en) STABLE COMPOSITIONS OF ESOTRERODINE
HK1216843A1 (zh) 用於施用奧昔布寧的方法和組合物
EP2814907A4 (en) BORBASTLASTED LIQUID SCINTILLATE COMPOSITIONS AND METHOD OF MANUFACTURING THEREOF
HK1212998A1 (zh) 組合物及其使用方法
EP2841164A4 (en) COMPOSITIONS AND USE PROCEDURES FOR THE SKIN
AU2012905317A0 (en) Methods and Preparation and Use of Xanthorrhoeaceae Compositions
AU2012901658A0 (en) Compositions and methods of use